Steve Powell

1.3k total citations
19 papers, 527 citations indexed

About

Steve Powell is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Steve Powell has authored 19 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Steve Powell's work include DNA Repair Mechanisms (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and TGF-β signaling in diseases (2 papers). Steve Powell is often cited by papers focused on DNA Repair Mechanisms (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and TGF-β signaling in diseases (2 papers). Steve Powell collaborates with scholars based in United Kingdom, United States and Switzerland. Steve Powell's co-authors include Martin Pass, Mark J. Anderton, Annabelle Heier, Alex Bell, Ruth Roberts, Howard R. Mellor, C Sadler, Richard Peer, Lars Boman and Syde A. Taheri and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Steve Powell

19 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Powell United Kingdom 11 227 175 153 118 85 19 527
Yushen Wu China 14 215 0.9× 213 1.2× 92 0.6× 114 1.0× 19 0.2× 25 532
Josef Kovařík United Kingdom 10 62 0.3× 169 1.0× 98 0.6× 139 1.2× 38 0.4× 42 449
Aurélie Ferru France 11 93 0.4× 250 1.4× 39 0.3× 82 0.7× 16 0.2× 30 439
Kazunari Maekawa Japan 12 85 0.4× 145 0.8× 97 0.6× 100 0.8× 35 0.4× 32 428
Jia-Jia Huang China 15 115 0.5× 324 1.9× 49 0.3× 60 0.5× 12 0.1× 25 575
Amer Sami Canada 12 184 0.8× 344 2.0× 33 0.2× 85 0.7× 7 0.1× 23 551
Judy Pang United States 15 86 0.4× 326 1.9× 333 2.2× 121 1.0× 37 0.4× 41 815
Smitha Menon United States 11 134 0.6× 300 1.7× 29 0.2× 128 1.1× 17 0.2× 18 474
Sven Borchmann Germany 15 83 0.4× 298 1.7× 24 0.2× 110 0.9× 20 0.2× 46 612
Meihai Deng China 15 299 1.3× 96 0.5× 146 1.0× 133 1.1× 11 0.1× 45 667

Countries citing papers authored by Steve Powell

Since Specialization
Citations

This map shows the geographic impact of Steve Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Powell more than expected).

Fields of papers citing papers by Steve Powell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Powell. The network helps show where Steve Powell may publish in the future.

Co-authorship network of co-authors of Steve Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Powell. A scholar is included among the top collaborators of Steve Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Powell. Steve Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hay, Trevor, Robert McEwen, Urszula M. Polanska, et al.. (2019). Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours. Oncotarget. 10(27). 2586–2606. 25 indexed citations
2.
Yates, James, Susan Ashton, Darren A.E. Cross, et al.. (2016). Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic–Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104. Molecular Cancer Therapeutics. 15(10). 2378–2387. 34 indexed citations
3.
Savi, Chris De, Robert H. Bradbury, Alfred A. Rabow, et al.. (2015). Abstract 3650: Discovery of the clinical candidate AZD9496: a potent and orally bioavailable selective estrogen receptor downregulator and antagonist. Cancer Research. 75(15_Supplement). 3650–3650. 4 indexed citations
4.
Hancox, Urs J., Sabina Cosulich, Hannah Dry, et al.. (2013). Abstract 3264: AZD8186: a potent selective inhibitor of PI3Kβ targeting PTEN-deficient tumours dependent on dysregulated PI3Kβ signalling.. Cancer Research. 73(8_Supplement). 3264–3264. 2 indexed citations
5.
Bradford, James, Matthew R. Farren, Steve Powell, et al.. (2013). RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib. PLoS ONE. 8(6). e66003–e66003. 24 indexed citations
6.
Guichard, Sylvie M., Rajesh Odedra, Adina Hughes, et al.. (2013). Abstract 3343: The pre-clinical in vitro and in vivo activity of AZD6738: A potent and selective inhibitor of ATR kinase.. Cancer Research. 73(8_Supplement). 3343–3343. 18 indexed citations
7.
Farren, Matthew R., Susie Weston, Helen Brown, et al.. (2012). Expression of stromal genes associated with the angiogenic response are not differentiated between human tumour xenografts with divergent vascular morphologies. Angiogenesis. 15(4). 555–568. 6 indexed citations
8.
Jacq, Xavier, Lisa M. Smith, Adina Hughes, et al.. (2012). Abstract 1823: AZ20, a novel potent and selective inhibitor of ATR kinase with in vivo antitumour activity. Cancer Research. 72(8_Supplement). 1823–1823. 10 indexed citations
9.
Anderton, Mark J., Howard R. Mellor, Alex Bell, et al.. (2011). Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors. Toxicologic Pathology. 39(6). 916–924. 211 indexed citations
10.
Soond, Surinder M., et al.. (2010). Early phase TGFβ receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses. The International Journal of Biochemistry & Cell Biology. 43(4). 604–612. 29 indexed citations
11.
Rosner, Rita & Steve Powell. (2007). Überschätzt die ICD-10 die PTBS-Prävalenz?. Trauma und Gewalt. 1(1). 46–57. 5 indexed citations
12.
Stoner, Michael C., et al.. (2007). The use of intravascular ultrasound imaging to improve use of inferior vena cava filters in a high-risk bariatric population. Journal of Vascular Surgery. 46(6). 1248–1252. 11 indexed citations
13.
Stoner, Michael C., et al.. (2007). Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease. Journal of Vascular Surgery. 46(2). 289–295.e1. 37 indexed citations
14.
Rosner, Rita & Steve Powell. (2007). Überschätzt die ICD-10 die PTBS-Prävalenz? Auswirkungen unterschiedlicher Diagnosekriterien auf Diagnoseraten der Posttraumatischen Belastungsstörung nach Kriegstraumatisierung. 4 indexed citations
15.
Riegler, Peter, et al.. (2004). Continuous Crude Oil Characterization by a Radio Frequency Resonator (Kontinuierliche Rohöl-Bewertung mittels eines Hochfrequenzresonators). tm - Technisches Messen. 71(9). 486–491. 1 indexed citations
16.
Winkler, Hans & Steve Powell. (2003). Applications of RNA interference. 2(2). 42–44. 1 indexed citations
17.
Papaconstantinou, Harry T., et al.. (1998). Glutamate and asparagine protect against the induction of apoptosis in glutamine-deprived intestinal epithelial cells. Gastroenterology. 114. A899–A899. 1 indexed citations
18.
Kleinman, Bruce, Steve Powell, & Reed M. Gardner. (1996). Equivalence of fast flush and square wave testing of blood pressure monitoring systems. The Journal of Clinical Monitoring. 12(2). 149–154. 17 indexed citations
19.
Taheri, Syde A., et al.. (1987). Iliocaval compression syndrom. The American Journal of Surgery. 154(2). 169–172. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yushen Wu Breakdown of academic impact, for papers by Josef Kovařík Breakdown of academic impact, for papers by Aurélie Ferru Breakdown of academic impact, for papers by Kazunari Maekawa Breakdown of academic impact, for papers by Jia-Jia Huang Breakdown of academic impact, for papers by Amer Sami Breakdown of academic impact, for papers by Judy Pang Breakdown of academic impact, for papers by Smitha Menon Breakdown of academic impact, for papers by Sven Borchmann Breakdown of academic impact, for papers by Meihai Deng
Rankless by CCL
2026